This webinar will give you insights in the possibilities that E. coli fermentation systems can offer for manufacturing of therapeutic antibodies, including antibody fragments.
There will be special focus on our new fermentation technology, SCOPE® technology: a system for a controlled regulation of protein expression yields in E. coli with a case study to showcase the latest technological advancements.
Want to learn how you can produce your next therapeutic antibody in a highly cost-efficient way, watch the video now!
Sagrario Arias Rivas, Principal Scientist at Batavia Biosciences. She has over 10 years experience in Microbial Process Development for all major classes of biopharmaceuticals. Dr. Arias Rivas has a PhD on Molecular Biology and Biotechnology and is co-author of 5 patents and 16 scientific publications and book chapters.
Key learning objectives: